Comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 vs 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Isolated 17 20 Lyase Deficiency and 45 X 46 XY Mixed Gonadal Dysgenesis CN279762 for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
A rare condition involving deficiency of the 17,20-lyase enzyme needed for androgen synthesis. Affects 46,XY individuals and causes undervirilization. Managed with hormone therapy.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
A chromosomal variation affecting sexual development. Involves differences in gonadal tissue and may affect physical development. Care involves hormonal support and multidisciplinary management.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
0-0
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
0-0
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
severe
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
Chronic
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
No
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
reproductive
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
reproductive
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
endocrine
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-isolated-17-20-lyase-deficiency-C5681470 and 45-x-46-xy-mixed-gonadal-dysgenesis-CN279762 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Discriminating power |
|---|---|---|---|
| Genital appearance | 46,XY person may have undervirilization from reduced androgen production; range is not fixed. | Appearance can vary widely with asymmetric or streak gonadal tissue. | Moderate |
| Gonadal findings | Gonads are typically testes, although function may be impaired; this is not diagnostic alone. | Mixed or dysgenetic gonads, sometimes a streak gonad, may be present. | High |
| Associated features | Primarily a steroid-pathway problem; broader congenital anomalies are not established by these data. | Turner-like features or growth differences may occur but are not universal. | Moderate |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 when
46,XY karyotype with undervirilization
Supports considering an androgen-synthesis disorder rather than mosaicism.
Moderate
Steroid profile suggests isolated lyase impairment
Biochemical pattern, interpreted by a specialist, points toward the enzyme disorder.
Moderate
No mosaic cell line is identified
Absence of 45,X/46,XY mosaicism makes mixed gonadal dysgenesis less likely.
Moderate
Choose 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 when
Karyotype shows 45,X and 46,XY lines
Documented mosaicism is the defining evidence for this condition.
High
Asymmetric or streak gonads are found
Dysgenetic gonadal anatomy favors mixed gonadal dysgenesis.
Moderate
Turner-associated features are present
Such features may support mosaicism but do not prove it alone.
Low
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470 | 45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762 | Interpretation |
|---|---|---|---|
| Karyotype or chromosomal microarray | Typically 46,XY without a 45,X line. | 45,X/46,XY mosaicism. | Chromosomal testing is the strongest supplied discriminator. |
| Steroid hormone profile | Pattern may suggest impaired 17,20-lyase activity; exact cutoffs are not established here. | No specific lyase pattern is expected from these data. | Abnormal results are not a diagnosis and need specialist review. |
| Pelvic imaging or gonadal histology | Testicular tissue may be identified. | Mixed, dysgenetic, or streak gonadal tissue may be seen. | Anatomy supports classification but must be correlated with genetics. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Isolated 17 20 Lyase Deficiency C5681470
- Outcome
- Chronic endocrine condition; long-term outcome varies and is not quantified here.
- Factors
- Degree of enzyme impairment, hormone replacement, and associated findings.
45 X 46 Xy Mixed Gonadal Dysgenesis Cn279762
- Outcome
- Chronic genetic condition with variable development and gonadal risk.
- Factors
- Mosaic distribution, gonadal histology, growth, and hormone status.
Time frame: Often recognized in infancy or childhood, with lifelong follow-up.
Accurate genetics, hormone assessment, gonadal findings, and coordinated care.
Complications comparison
| Complication | Presentation |
|---|---|
| Hormone deficiency | Androgen deficiency and pubertal undervirilization may require hormone therapy. Sex-hormone insufficiency may require individualized hormonal support. Doses and regimens are not specified here. |
| Fertility potential | Fertility may be reduced, but outcome is not established from these data. Dysgenetic gonads often reduce fertility potential. Counseling should be individualized. |
| Gonadal tumor concern | Tumor risk is not quantified by the supplied source. Dysgenetic gonads can carry malignancy risk; surveillance decisions are specialist-led. Do not infer a specific risk percentage. |
Patient education highlights
- HighDiagnosis
These are different conditions; a test abnormality or physical finding alone does not establish either diagnosis.
- HighCare team
Endocrinology, genetics, urology or gynecology, and psychosocial support may all be relevant.
- MediumTreatment
Hormone therapy may be used, but choices depend on individual findings, goals, and clinician judgment.